• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Emergency

The use of a diagnostic strategy with age-adjusted D-dimer thresholds was non-inferior in risk-stratifying for thromboembolic events in emergency department patients with suspected pulmonary embolism

byYuchen DaiandMichael Pratte
December 10, 2021
in Emergency, Imaging and Intervention, Pulmonology
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. Compared to conventional diagnostic strategy, the use of the YEARS rule combined with the age-adjusted D-dimer threshold did not result in an inferior rate of thromboembolic events in patients with suspected pulmonary embolism in the emergency department.

2. The use of YEARS criteria in combination with the PERC criteria significantly decreased the use of chest imaging in this patient population, emphasizing the value of combining the 2 criteria sets with clinical assessment.

Evidence Rating Level: 1 (Excellent)

Study Rundown: The assessment algorithm and optimal diagnostic strategy to rule out suspected pulmonary embolism (PE) in patients varies across centers and is a much-debated subject. The YEARS rules and PERC rules combined with age-adjusted D dimer thresholds are diagnostic criteria strategies that use varying D-dimer thresholds to help safely rule out PE and have been validated in separate studies. However, their combination use has not been investigated in a randomized trial. This noninferiority trial assessed whether a strategy combining the YEARS rule with the age-adjusted D-dimer cutoff component of the PERC rule could help safely rule out the diagnosis of PE in suspected patients in the emergency department (ED). The primary endpoint was venous thromboembolism (VTE) at 3 months where the noninferiority margin was set at 1.35%. Secondary endpoints included chest imaging, ED length of stay, hospital admission, nonindicated anticoagulation treatment, all-cause death, and all-cause readmission at 3 months. Among 1,414 patients with clinically suspected PE, the 3-month risk of a missed VTE event using the intervention diagnostic strategy vs conventional strategy was 0.15% vs 0.80%, below the noninferiority margin. These results suggested that compared to conventional diagnostic strategy, the use of the YEARS rule combined with the age-adjusted D-dimer threshold in PERC-positive patients did not result in an inferior rate of VTE events in ED patients with suspected PE. A limitation of this study was that the 2 patient groups may have had confounding, clinically relevant differences that occurred because of the center-level randomization, as opposed to patient-level.

Click to read the study in JAMA

Click to read an accompanying editorial in JAMA

Relevant Reading: Modified diagnostic strategy to safely rule-out pulmonary embolism in the emergency department: study protocol for the non-inferiority MODIGLIANI cluster cross-over randomized trial

RELATED REPORTS

Heparin in noncritically ill COVID-19 patients [Classics Series]

Routine primary thromboprophylaxis with enoxaparin safe in children with COVID-19 or MIS-C

SARS-CoV-2 infection during pregnancy associated with severe maternal morbidity, preterm birth, and venous thromboembolism

In-Depth [randomized clinical trial]: This cluster-randomized, crossover, noninferiority trial included 1,414 patients (mean age, 55 years; 58% female) from 18 EDs in France and Spain between October 2019 to June 2020. Inclusion criteria included patients with a low clinical risk of PE not excluded by the PERC rule or a subjective clinical intermediate risk of PE. In the randomized intervention period (N = 726), PE was excluded without chest imaging in patients with no YEARS criteria and a D-dimer level less than 1,000 ng/mL and in patients with 1 or more YEARS criteria and a D-dimer level less than the age-adjusted threshold (500 ng/mL if age <50 years or age in years x 10 in patients ≥50 years). In the control period (N = 688), PE was excluded without chest imaging if the D-dimer level was less than the age-adjusted threshold. In total, PE was diagnosed in 100 patients (7.1%) where VTE was subsequently diagnosed at 3 months in 1 patient in the intervention group (0.15% [95%CI, 0.0%to 0.86%]) compared to 5 patients in the control group (0.80% [95%CI, 0.26% to 1.86%]) (adjusted difference, −0.64% [1-sided 97.5%CI, −∞ to 0.21%], within the noninferiority margin). Among secondary endpoints, only 2 showed a statistically significant difference between the intervention vs control groups: chest imaging (30.4% vs 40.0%; adjusted difference, −8.7% [95%CI, −13.8% to −3.5%]) and ED median length of stay (6 hours [IQR, 4 to 8 hours] vs 6 hours [IQR, 5 to 9 hours]; adjusted difference, −1.6 hours [95%CI, −2.3 to −0.9]).

Image: PD

©2021 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: d-dimerpulmonary embolismvenous thromboembolism (VTE)
Previous Post

Mental health apps improve well-being, mental health, and emotional regulation

Next Post

2 Minute Medicine Rewind December 13, 2021

RelatedReports

The ABCD2 score: Risk of stroke after Transient Ischemic Attack (TIA) [Classics Series]
COVID-19 Classics

Heparin in noncritically ill COVID-19 patients [Classics Series]

July 17, 2022
siRNA against antithrombin alleviates symptoms of hemophilia [PreClinical]
Hematology

Routine primary thromboprophylaxis with enoxaparin safe in children with COVID-19 or MIS-C

July 12, 2022
Decreased expression of nasal ACE2 may be correlated with lower prevalence of COVID-19 in children
Hematology

SARS-CoV-2 infection during pregnancy associated with severe maternal morbidity, preterm birth, and venous thromboembolism

March 24, 2022
siRNA against antithrombin alleviates symptoms of hemophilia [PreClinical]
Chronic Disease

Venous thromboembolism rates in hospitalized children continue to rise

February 14, 2022
Next Post
American Academy of Pediatrics recommends standards for adverse event disclosures

2 Minute Medicine Rewind December 13, 2021

Novel coronavirus identified from patients with pneumonia in Wuhan, China

Cognitive emotion regulation strategies may help predict depression and anxiety levels during COVID-19  

Thoracic radiotherapy improves survival in small-cell lung cancer patients

Poziotinib reduces tumour size in patients with previously treated HER2 mutation positive non-small-cell lung cancer

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Ciprofol comparable to propofol for general anesthesia induction for gynecological surgery
  • Moderate-intensity statin plus ezetimibe is non-inferior to high-intensity statin monotherapy
  • Type of compensation model influences gender pay gap in primary care
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.